Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

375
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
375
Allergic Reactions02:06

Allergic Reactions

28.1K
Overview
28.1K
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

1.9K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.9K
Allergic Drug Reactions01:27

Allergic Drug Reactions

911
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
911

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SHIP1 is required for T cell surveillance of occult malignancies.

Cellular and molecular life sciences : CMLS·2026
Same author

Rescue Inhaler Overuse in Severe Asthma: A Real-World Study of Short-Acting β<sub>2</sub>-Agonist and Short-Acting Muscarinic Antagonist Use.

Biomedicines·2026
Same author

Respiratory Viruses, Self-Diagnosis, Early Treatment and Prophylaxis.

Viruses·2026
Same author

Melittin in AllergoOncology: From Honey Bee Venom to Anti-Cancer Therapeutic Innovation-An EAACI Position Paper.

Allergy·2026
Same author

Biological drugs for the treatment of children with atopic dermatitis.

Expert opinion on biological therapy·2026
Same author

A Multi-Compartment Cytological Approach to Severe Asthma Phenotyping: The BRISA Study (Biomedical Research in Severe Asthma).

Journal of asthma and allergy·2026

Related Experiment Video

Updated: Aug 7, 2025

An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation
08:25

An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation

Published on: April 27, 2021

2.5K

Multistep IgE Mast Cell Desensitization Is a Dose- and Time-Dependent Process Partially Regulated by SHIP-1.

Ather Adnan1,2, Shree Acharya2, Leila A Alenazy1,3

  • 1Division of Allergy and Immunology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Journal of Immunology (Baltimore, Md. : 1950)
|March 7, 2023
PubMed
Summary

Multistep mast cell desensitization prevents mediator release by regulating dose and timing. This process blocks immune responses by impacting cytoskeletal changes and favoring early SHIP-1 phosphorylation, crucial for desensitization.

More Related Videos

Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays
11:31

Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays

Published on: July 4, 2018

12.4K
Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
09:07

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice

Published on: May 27, 2015

10.5K

Related Experiment Videos

Last Updated: Aug 7, 2025

An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation
08:25

An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation

Published on: April 27, 2021

2.5K
Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays
11:31

Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays

Published on: July 4, 2018

12.4K
Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
09:07

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice

Published on: May 27, 2015

10.5K

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Multistep mast cell desensitization safely reintroduces allergens in sensitized individuals.
  • The precise mechanisms underlying mast cell desensitization remain incompletely understood.

Purpose of the Study:

  • To investigate the kinetics, membrane, and cytoskeletal alterations during mast cell desensitization.
  • To identify molecular targets involved in the inhibitory process of IgE-mediated mast cell activation.

Main Methods:

  • Utilized wild-type murine and FcεRIα humanized bone marrow mast cells.
  • Assessed receptor movements, cytoskeletal dynamics (actin, tubulin), and protein phosphorylation (Syk, Lyn, P38-MAPK, SHIP-1).
  • Employed SHIP-1 protein silencing to determine its role in desensitization.

Main Results:

  • Desensitization blocked β-hexosaminidase release in an antigen-specific manner and prevented cytoskeletal rearrangements.
  • Desensitization efficacy depended on antigen dose, dose frequency, and timing.
  • Early desensitization showed increased SHIP-1 phosphorylation, independent of its phosphatase activity, while silencing SHIP-1 impaired desensitization.

Conclusions:

  • Multistep IgE mast cell desensitization is a regulated process impacting mediator release and cytoskeletal dynamics.
  • Signal transduction is altered, with early SHIP-1 phosphorylation playing a key role.
  • SHIP-1 is essential for effective mast cell desensitization, independent of its phosphatase activity.